(OrthoFeed) – The field of orthopedics is undergoing a transformative phase with innovative startups pushing the boundaries of technology to improve patient outcomes and revolutionize the way orthopedic care is delivered. In 2024, the following 10 orthopedic startups are poised […]
EpiBone has received Investigational New Drug (IND) clearance from the FDA to begin testing its lab-grown knee cartilage in humans. The treatment, known as an engineered allogenic osteochondral graft, has shown promise in pre-clinical studies and could benefit people with damaged knee cartilage caused by sports injuries, trauma or post-traumatic arthritis. […]
A Janus-faced biomaterial that firmly adheres to injured tendons and helps them glide, also slowly releases drugs to tendon cells, which could improve repair in patients across multiple injuries […]
Northwestern University researchers have developed a new injectable therapy that harnesses “dancing molecules” to reverse paralysis and repair tissue after severe spinal cord injuries. […]
Arthrex to receive exclusive rights to distribute and commercialize Celularity’s placental-derived biomaterial products for orthopedics and sport medicine in the United States. […]
Copyright © 2026 | MH Magazine WordPress Theme by MH Themes